It is a known fact that ESM-1 is mainly produced by vascular endothelial cells in humans.[11,35] It seems reasonable to hypothesize that increased serum levels of ESM-1 reflect the activation of the tumor vascular bed and perhaps tumor proliferation in patients with lung cancer. This evidence concerns the gene ESM1 and neoplasm.